Ann Hunter
About
Ann Hunter is a scholar working on Hematology, Molecular Biology and Oncology.
According to data from OpenAlex, Ann Hunter has authored 70 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 24 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Ann Hunter's work include Acute Myeloid Leukemia Research (11 papers), Hematopoietic Stem Cell Transplantation (10 papers) and Glycosylation and Glycoproteins Research (8 papers). Ann Hunter is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Hematopoietic Stem Cell Transplantation (10 papers) and Glycosylation and Glycoproteins Research (8 papers). Ann Hunter collaborates with scholars based in United Kingdom, United States and Switzerland. Ann Hunter's co-authors include Nigel H. Russell, Robert K. Hills, Alan K. Burnett, Donald Milligan, David J. Harvey, Jonathan Kell, Raymond A. Dwek, Keith Wheatley, Anthony H. Goldstone and Bernhard Küster and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Oncology.
In The Last Decade
Ann Hunter
70 papers receiving 3.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ann Hunter United Kingdom | 31 | 2.1k | 1.5k | 863 | 648 | 608 | 70 | 4.0k | ||
| Brian Booth United States | 30 | 518 0.3× | 1.6k 1.1× | 1.3k 1.5× | 815 1.3× | 178 0.3× | 77 | 4.6k | ||
| Philip J. Burke United States | 35 | 1.3k 0.6× | 1.8k 1.2× | 1.6k 1.8× | 275 0.4× | 529 0.9× | 109 | 4.8k | ||
| Michael Hayes United States | 33 | 1.2k 0.6× | 1.2k 0.8× | 574 0.7× | 174 0.3× | 164 0.3× | 97 | 4.1k | ||
| Helen K. Chew United States | 34 | 580 0.3× | 1.0k 0.7× | 1.4k 1.7× | 221 0.3× | 394 0.6× | 89 | 5.4k | ||
| Étienne Chatelut France | 43 | 643 0.3× | 1.8k 1.2× | 2.6k 3.1× | 283 0.4× | 406 0.7× | 234 | 6.6k | ||
| Michelle A. Rudek United States | 48 | 947 0.5× | 3.8k 2.5× | 2.5k 2.9× | 359 0.6× | 254 0.4× | 239 | 7.2k | ||
| Angélo Paci France | 31 | 413 0.2× | 1.0k 0.7× | 850 1.0× | 226 0.3× | 226 0.4× | 201 | 3.5k | ||
| Carolyn A. Felix United States | 36 | 1.4k 0.7× | 2.5k 1.7× | 1.1k 1.2× | 132 0.2× | 1.2k 2.0× | 85 | 4.1k | ||
| Raymond J. Hohl United States | 40 | 616 0.3× | 2.3k 1.5× | 1.5k 1.8× | 446 0.7× | 145 0.2× | 138 | 4.9k | ||
| William D. Figg United States | 52 | 950 0.5× | 4.6k 3.1× | 3.1k 3.6× | 625 1.0× | 135 0.2× | 234 | 10.3k |
Countries citing papers authored by Ann Hunter
Since
Specialization
Citations
This map shows the geographic impact of Ann Hunter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Hunter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Hunter more than expected).
Fields of papers citing papers by Ann Hunter
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ann Hunter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Hunter. The network helps show where Ann Hunter may publish in the future.
Co-authorship network of co-authors of Ann Hunter
This figure shows the co-authorship network connecting the top 25 collaborators of Ann Hunter. A scholar is included among the top collaborators of Ann Hunter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Hunter. Ann Hunter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Coles, Simon J., et al.. (2025). The synthesis, structure and solution and gas phase properties of complexes of scandium and lanthanide triflates with the phosphine oxide ligands PhP(O)(C2H4P(O)Ph2)2 and P(O)(C2H4P(O)Ph2)3. Polyhedron. 269. 117395–117395.
2.
Godfrey, A. Ruth, Anthony Gravell, Ann Hunter, et al.. (2022). Use of QuEChERS as a manual and automated high-throughput protocol for investigating environmental matrices. Chemosphere. 308(Pt 2). 136313–136313.
3.
Rule, Simon, Gordon Cook, Nigel H. Russell, et al.. (2018). Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphoma. British Journal of Haematology. 184(6). 999–1005.
4.
Burnett, Alan K., Nigel H. Russell, Robert K. Hills, et al.. (2015). Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial. The Lancet Oncology. 16(13). 1295–1305.
5.
Burnett, Alan K., Robert K. Hills, David Grimwade, et al.. (2012). Inclusion of chemotherapy in addition to anthracycline in the treatment of acute promyelocytic leukaemia does not improve outcomes: results of the MRC AML15 trial. Leukemia. 27(4). 843–851.
6.
Rovó, Alicia, Mahmoud Aljurf, S Chiodi, et al.. (2012). Ongoing graft-versus-host disease is a risk factor for azoospermia after allogeneic hematopoietic stem cell transplantation: a survey of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Haematologica. 98(3). 339–345.
7.
Hunter, Ann, et al.. (2007). Synthesis, structures and mass spectrometry of lanthanide nitrate complexes with tricyclohexylphosphine oxide. Polyhedron. 26(17). 4865–4876.
8.
Hunter, Hannah, Karl S. Peggs, R Powles, et al.. (2005). Analysis of outcome following allogeneic haemopoietic stem cell transplantation for myeloma using myeloablative conditioning – evidence for a superior outcome using melphalan combined with total body irradiation. British Journal of Haematology. 128(4). 496–502.
9.
Tauro, Sudhir, Charles Craddock, Karl S. Peggs, et al.. (2005). Allogeneic Stem-Cell Transplantation Using a Reduced-Intensity Conditioning Regimen Has the Capacity to Produce Durable Remissions and Long-Term Disease-Free Survival in Patients With High-Risk Acute Myeloid Leukemia and Myelodysplasia. Journal of Clinical Oncology. 23(36). 9387–9393.
10.
Peggs, K, Premini Mahendra, D W Milligan, et al.. (2003). Long term results of reduced intensity transplantation in multiply relapsed and refractory Hodgkin's lymphoma: Evidence of a therapeutically relevant graft-versus-lymphoma effect.. UCL Discovery (University College London).
11.
Shaw, Bronwen E., Karl S. Peggs, Jennifer M. Bird, et al.. (2003). The outcome of unrelated donor stem cell transplantation for patients with multiple myeloma. British Journal of Haematology. 123(5). 886–895.
12.
Morris, Emma, Charles Craddock, D Milligan, et al.. (2002). Long-term follow-up of an alemtuzumab (CAMPATH-1H) containing reduced intensity allogeneic transplant regimen for non-Hodgkin's lymphoma (NHL).. UCL Discovery (University College London).
13.
Zamze, Susanne, David Wing, Mark R. Wormald, et al.. (2001). A family of novel, acidic N‐glycans in Bowes melanoma tissue plasminogen activator have L2/HNK‐1‐bearing antennae, many with sulfation of the fucosylated chitobiose core. European Journal of Biochemistry. 268(14). 4063–4078.
14.
Harvey, David J., et al.. (1999). Relationship between in-source and post-source fragment ions in the matrix-assisted laser desorption (ionization) mass spectra of carbohydrates recorded with reflectron time-of-flight mass spectrometers. International Journal of Mass Spectrometry. 188(1-2). 131–146.
15.
Hunter, Ann, et al.. (1998). [Experiences with introduction of the UNICEF program "10 steps for successful breast feeding"].. PubMed. 202(3). 102–6.
16.
Turzanski, Julie, S. P. M. Crouch, John Fletcher, & Ann Hunter. (1997). Ex vivo neutrophil function in response to three different doses of glycosylated rHuG‐CSF (Lenograstim). British Journal of Haematology. 96(1). 46–54.
17.
Marshall, Aileen, John F. Darbyshire, Ann Hunter, Peter McPhie, & William B. Jakoby. (1997). Control of Activity through Oxidative Modification at the Conserved Residue Cys66 of Aryl Sulfotransferase IV. Journal of Biological Chemistry. 272(14). 9153–9160.
18.
Hunter, Ann & David E. Games. (1995). Evaluation of glycosylation site heterogeneity and selective identification of glycopeptides in proteolytic digests of bovine α1‐acid glycoprotein by mass spectrometry. Rapid Communications in Mass Spectrometry. 9(1). 42–56.
19.
Hunter, Ann. (1992). Total Quality Management in Health Care. Physiotherapy. 78(7). 550–550.
20.
Hunter, Ann. (1992). Health Service Quality: An introduction to quality methods for health services. Physiotherapy. 78(5). 387–387.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Brian Booth Breakdown of academic impact, for papers by Philip J. Burke Breakdown of academic impact, for papers by Michael Hayes Breakdown of academic impact, for papers by Helen K. Chew Breakdown of academic impact, for papers by Étienne Chatelut Breakdown of academic impact, for papers by Michelle A. Rudek Breakdown of academic impact, for papers by Angélo Paci Breakdown of academic impact, for papers by Carolyn A. Felix Breakdown of academic impact, for papers by Raymond J. Hohl Breakdown of academic impact, for papers by William D. Figg